SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-19-095230
Filing Date
2019-04-02
Accepted
2019-04-02 09:13:34
Documents
4
Group Members
CASCADE MERGER SUB INC.MERCK SHARP & DOHME CORP.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d745225dsctota.htm SC TO-T/A 26807
2 EXHIBIT (A)(5)(C) d745225dex99a5c.htm EX-99.(A)(5)(C) 8620
3 GRAPHIC g745225g0401103513781.jpg GRAPHIC 3512
4 GRAPHIC g745225g0401103513900.jpg GRAPHIC 1264
  Complete submission text file 0001193125-19-095230.txt   44363
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filed by) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 GATEWAY BOULEVARD SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address 1616 EASTLAKE AVENUE E. SUITE 310 SEATTLE WA 98102 (650) 392-8350
IMMUNE DESIGN CORP. (Subject) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-88256 | Film No.: 19722975
SIC: 2834 Pharmaceutical Preparations